Bio-Works Technologies operates in biotechnology. The company develops products that separate and purify molecules in the production of pharmaceuticals. The technology is based on chromatography, which is intended to handle the drug substance. Customers are found in the European market where the products are sold via distribution partners and to companies in the pharmaceutical industry, as well as research institutes and universities. The company was founded in 2006 and has its headquarters in Uppsala.
CEO
Chairperson of the Board
Board
| Name | Capital % | Votes % | Date |
|---|---|---|---|
| Swedia Capital | 22,70 | 22,70 | 2025-12-23 |
| Erik Åfors | 18,81 | 18,81 | 2025-12-23 |
| Avanza Pension | 4,23 | 4,23 | 2025-12-23 |
| Peter von Ehrenheim | 3,92 | 3,92 | 2025-12-23 |
| Laurent Leksell med bolag | 3,55 | 3,55 | 2025-12-23 |
| Futur Pension | 2,86 | 2,86 | 2025-12-23 |
| Dariush Hosseinian | 2,72 | 2,72 | 2025-12-23 |
| Nordnet Pensionsförsäkring | 1,78 | 1,78 | 2025-12-23 |
| Olof Mathias Malmgren | 1,31 | 1,31 | 2025-12-23 |
| Lennart Ericsson Värdepapper AB | 1,19 | 1,19 | 2025-12-23 |
2026-05-13 Interim Report 2026-Q1
2026-06-04 Annual General Meeting 2025
2026-08-21 Interim Report 2026-Q2
2026-11-06 Interim Report 2026-Q3
2027-02-19 Year End Report 2026
